NPPA fixes retail price of 1 formulation: September 2021

Download the notification S.O. No. 3783(E) dated 15-09-2021

NPPA Price of drugs

Last Updated on September 27, 2021 by The Health Master

Download the notification: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of one (1) formulation under the Drugs (Prices Control) Order, 2013, based on the decision of the Authority meeting held on July 29, 2021 vide notification S.O. 3783(E) dated 15-09-2021.

NPPA, in its order on September 15, listed the one (1) formulation for which it has fixed retail prices. List of the formulations has been given below


Sl. No.Name of the FormulationDosage form & StrengthUnitRetail Price (Rs.)DoP Letter no. and DateExisting SO number & dateManufacturer & Marketing Company respectively
1.Vitamin D3Each orallyPer30.39 1724(E)M/s Zim
 (Cholecalciferol)disintegrating stripsStrip 31015/06/2021-datedLaboratories
 orallycontains:  Pricing    (16530)30.04.2021Ltd. / M/s Cadila
 disintegratingVitamin D3  dated(at Sl. No.Pharmaceuticals
 strips(Cholecalciferol) IP  08.09.202120)Ltd.
  60000 IU     

The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove.

The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (5) of the above said table.


The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

Latest notifications – DPCO /NPPA

FAQs – On DPCO: Drugs (Prices Control) Order, 2013

The above mentioned retail prices are applicable only to the manufacturer / marketer as mentioned above for generic / any brand of the same composition / strength of the subject formulations, subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including

manufacturing license permission from the Competent Authority i.e. the Central / State Licensing Authority, as may be applicable, by the concerned manufacturers/marketing companies.

In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

NPPA extends ceiling price regulation on Orthopaedic knee implants

NPPA extends price cap on LMO and Oxygen inhalation

NPPA panel recommends 15% rise in ceiling price for 3 formulations

NPPA fixes retail price of 19 formulations

NPPA releases draft of Retail Price proposals for 11 Drugs

NPPA caps on trade margin of 42 Non Scheduled Cancer Drugs

Classifications of Medical Devices under the provisions of MDR 2017

Lupin gets 7 observations from USFDA

Aurobindo Pharma gets Indian patent for this Antiviral Drug

Vaccination for 12+ in India likely to start start next month

India and Pharmacy Education: Chapter: 8

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner